Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Saroglitazar Boosts Response Rates in Primary Biliary Cholangitis

Saroglitazar Boosts Response Rates in Primary Biliary Cholangitis
ShareXFacebook

(MedPage Today) -- Novel saroglitazar significantly improved biochemical response rates in patients with primary biliary cholangitis (PBC) who had an inadequate response to ursodeoxycholic acid or couldn't tolerate it, according to the EPICS-III...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

The Pro-Life Movement's Cruelty Problem
MedPage Today

The Pro-Life Movement's Cruelty Problem

(MedPage Today) -- She stays quiet because of her child, my patient tells me. But despite her passivity, her husband always manages to find something wrong with her. He shouts at ungodly volumes, threatening, "Don't make me do something to you...

Read more →
Risk of Tardive Dyskinesia Higher in Women
MedPage Today

Risk of Tardive Dyskinesia Higher in Women

(MedPage Today) -- Patients taking antidopaminergic agents are at risk of developing tardive dyskinesia (TD), a disorder characterized by abnormal, involuntary movements of the face, trunk, and limbs. However, women may face a higher risk than...

Read more →
Advertisement